Daniel E Furst
Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab.
Rubbert-Roth A, Furst D, Fiore S, Praestgaard A, Bykerk V, Bingham C, Charles-Schoeman C, Burmester G. Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab. Arthritis Res Ther 2022; 24:207.
Aug 25, 2022Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab.
Aug 25, 2022Arthritis Res Ther 2022; 24:207
Rubbert-Roth Andrea, Furst Daniel E, Fiore Stefano, Praestgaard Amy, Bykerk Vivian, Bingham Clifton O, Charles-Schoeman Christina, Burmester Gerd R
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).
Mueller R, Schulze-Koops H, Furst D, Cohen S, Kwok K, Wang L, Killeen T, von Kempis J. Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel). Clin Rheumatol 2022; 41:1045-1055.
Jan 1, 2022Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).
Jan 1, 2022Clin Rheumatol 2022; 41:1045-1055
Mueller Ruediger B, Schulze-Koops Hendrik, Furst Daniel E, Cohen Stanley B, Kwok Kenneth, Wang Lisy, Killeen Tim, von Kempis Johannes
A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases
Rubbert-Roth A, Furst D, Nebesky J, Jin A, Berber E. A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases. Rheumatol Ther 2018; 5:21-42.
Mar 3, 2018A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases
Mar 3, 2018Rheumatol Ther 2018; 5:21-42
Rubbert-Roth Andrea, Furst Daniel E, Nebesky Jan Michael, Jin Angela, Berber Erhan